2. Gene
  3. AGER - advanced glycosylation end-product specific receptor Gene

AGER - advanced glycosylation end-product specific receptor Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Macaca fascicularis
Gene ID: 102121124 | Gene type: protein coding

About AGER

AGER Products(1)

mRNA Protein Name
XM_005553399.3 XP_005553456.2 advanced glycosylation end product-specific receptor
Protein Preferred Names Protein Names

advanced glycosylation end product-specific receptor

Related Agents

Approval
Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0146 Verteporfin 99.58% Yes
HY-16561 Resveratrol 99.94% Yes
HY-113416 Dehydroepiandrosterone sulfate 99.93% Unkown
HY-B0167A Sodium Salicylate 99.93% Yes
HY-147080 Avacincaptad pegol sodium Inhibitor 98.53% Unkown
HY-109561 Pegaptanib sodium Inhibitor 98.09% Unkown
HY-W012382 N-Acetyl-L-tyrosine 99.46% Unkown
HY-14892 Gemigliptin Inhibitor / Unkown
HY-B0146R Verteporfin (Standard) / Unkown
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-108801 Aflibercept Inhibitor 97.90% Unkown
HY-P99116 Faricimab Inhibitor 97.97% Unkown
Clinical Phase
Bioactive Molecules (36)
Cat. No. Product Name Effect
Purity Phase
HY-I0626 Cytosine 99.99% Phase 4
HY-W013494 L-Carnosine 99.94% Phase 3
HY-106024B Alagebrium chloride Inhibitor 99.93% Phase 3
HY-P0033 Argireline Inhibitor 99.43% Phase 3
HY-19720A Emixustat hydrochloride 99.29% Phase 3
HY-19720 Emixustat Inhibitor 98.00% Phase 3
HY-B1745 Pyridoxylamine 99.91% Phase 3
HY-16467 Squalamine lactate Inhibitor 98.27% Phase 3
HY-116098 Anecortave desacetate 98.36% Phase 3
HY-153484A Bevasiranib sodium Inhibitor / Phase 3
HY-153484 Bevasiranib Inhibitor / Phase 3
HY-P0033A Argireline acetate Inhibitor / Phase 3
HY-112499 Menaquinone-7 ≥98.0% Phase 2
HY-128973 Pyropheophorbide-a ≥98.0% Phase 2
HY-128850 N-Acetyl-D-mannosamine ≥98.0% Phase 2
HY-P3204 POT-4 Inhibitor 99.64% Phase 2
HY-10186 TG 100801 Inhibitor 98.61% Phase 2
HY-136788 ALK4290 Inhibitor 99.79% Phase 2
HY-112499R Menaquinone-7 (Standard) / Phase 2
HY-14564 GTS-21 Agonist / Phase 2
HY-150177 Mannose 6 phosphate / Phase 2
HY-P1930 Risuteganib Inhibitor / Phase 2
HY-P3204A POT-4 TFA Inhibitor / Phase 2
HY-P5285 Lunasin Inhibitor 95.60% Phase 2
HY-W250163 NAD+ lithium / Phase 2
HY-10187 TG 100801 Hydrochloride Inhibitor / Phase 2
HY-N0088 Apocynin Inhibitor 99.94% Phase 1
HY-W050154 Kojic acid Inhibitor 99.99% Phase 1
HY-N0160 Kinetin 99.47% Phase 1
HY-136093A Lixumistat acetate Activator 99.88% Phase 1
HY-N1420 Rhamnose ≥98.0% Phase 1
HY-15114 S 17092 Inhibitor 99.78% Phase 1
HY-N1420A Rhamnose monohydrate ≥98.0% Phase 1
HY-136093 Lixumistat hydrochloride Activator 99.25% Phase 1
HY-16387 PF 00337210 Inhibitor / Phase 1
HY-19692 Itasetron Antagonist / Phase 1
Inhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Phase
HY-108801A Aflibercept (VEGF Trap) Inhibitor 97.66% Phase 4
HY-P99298 Lampalizumab Inhibitor 99.46% Phase 3
HY-P99576 Tarcocimab Inhibitor 98.35% Phase 3
HY-P99629 Galegenimab Inhibitor 99.91% Phase 2
Pre-clinical Phase
Bioactive Molecules (218)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-131042 NNMTi Inhibitor 99.80% Unkown
HY-N0664 Aucubin Inhibitor 99.49% Unkown
HY-W250118 Phosphatidylethanolamine Activator ≥98.0% Unkown
HY-N1485 Cycloastragenol Activator ≥98.0% Unkown
HY-N0568 Madecassoside 99.58% Unkown
HY-N0033 Poliumoside Inhibitor 99.80% Unkown
HY-126255 SBI-797812 Activator 99.88% Unkown
HY-147313 TH10785 Activator 99.93% Unkown
HY-103157 PD146176 ≥99.0% Unkown
HY-147059 Dieckol 99.81% Unkown
HY-N0295 Protocatechualdehyde Inhibitor 99.98% Unkown
HY-120912 Gingerenone A Activator 99.95% Unkown
HY-129460 XJB-5-131 Inhibitor 99.9% Unkown
HY-P2048A MOTS-c(human) acetate Activator 98.97% Unkown
HY-W015924 2-Hydroxyisobutyric acid ≥98.0% Unkown
HY-11068 SB 239063 Inhibitor 99.61% Unkown
HY-16561R Resveratrol (Standard) 99.73% Unkown
HY-P3252A Pegcetacoplan acetate Inhibitor 99.74% Unkown
HY-129380 Fructosyl-lysine ≥97.0% Unkown
HY-150069 UBX1325 99.16% Unkown
HY-125623 MitoPerOx 98.14% Unkown
HY-110195 Smurf1-IN-A01 99.81% Unkown
HY-402361 TERT activator-1 99.50% Unkown
HY-W003607 3-O-Ethyl-L-ascorbic acid Inhibitor ≥98.0% Unkown
HY-137817 BCH001 Inhibitor 98.83% Unkown
HY-N0012 Glycitin Inhibitor 99.71% Unkown
HY-P1928 Humanin Inhibitor 99.83% Unkown
HY-N2292 Kinsenoside 99.91% Unkown
HY-N5135 Liriopesides B 99.92% Unkown
HY-P1149A Epitalon TFA Activator 99.62% Unkown
HY-W013573 S-Allyl-L-cysteine Inducer 98.64% Unkown
HY-17442 Azathramycin Inhibitor 99.85% Unkown
HY-107811 Harmol 99.77% Unkown
HY-P1149 Epitalon Activator 99.50% Yes
HY-108036 Pro-xylane (30% in water) ≥98.0% Unkown
HY-159062 Goji Extract Activator / Unkown
HY-B1745A Pyridoxylamine dihydrochloride 99.93% Unkown
HY-N4170 Chebulic acid 99.26% Unkown
HY-108036A (S)-Pro-xylane ≥98.0% Unkown
HY-N2485 4'-Methoxyresveratrol 99.48% Unkown
HY-14892A Gemigliptin tartrate Inhibitor 98.17% Unkown
HY-113303 FAPy-adenine 99.95% Unkown
HY-129566 Withanolide B Activator ≥99.0% Unkown
HY-N6818 5,​7,​4'-​Trimethoxyflavone 99.65% Unkown
HY-106353 Smilagenin Agonist ≥98.0% Yes
HY-N4089 Quercetin 3-gentiobioside Inhibitor 99.92% Unkown
HY-101528 IDRA 21 Modulator 99.33% Unkown
HY-128387 2,3-Butanediol 99.87% Unkown
HY-128463 N-tert-Butyl-α-phenylnitrone Inhibitor 99.94% Unkown
HY-76383 LR-90 Inhibitor 99.59% Unkown
HY-N1517 Ganoderic acid C2 99.30% Unkown
HY-N6588 3,4,5-Tricaffeoylquinic acid Inhibitor 98.71% Unkown
HY-N7690 3,5,7,3′,4′-Pentamethoxyflavone Inhibitor 99.15% Unkown
HY-133968 24-Methylenecholesterol 99.48% Unkown
HY-129380A Fructosyl-lysine dihydrochloride ≥95.0% Unkown
HY-B1169 Timonacic ≥98.0% Unkown
HY-B1340 Carbadox Inhibitor ≥98.0% Unkown
HY-N2278 Kushenol A Inhibitor 99.98% Unkown
HY-N3026 Soyasaponin Ab 99.20% Unkown
HY-P5904 Caveolin-1 (82-101) amide (human, mouse, rat) Inhibitor 98.48% Unkown
HY-15289 Ciproxifan maleate Antagonist 99.75% Unkown
HY-16561S Resveratrol-d4 99.36% Unkown
HY-156781 Sirtuin-1 inhibitor 1 Inhibitor 98.09% Unkown
HY-154847 WM-662 Inhibitor 99.48% Unkown
HY-110291 A-971432 Agonist ≥99.0% Unkown
HY-N2550A (+)-Coclaurine hydrochloride Control 99.09% Unkown
HY-N3127 Orobol Inhibitor 99.28% Unkown
HY-117924 AUTEN-67 Inducer ≥92.0% Unkown
HY-114653 SRPIN803 Inhibitor 99.17% Unkown
HY-118060 Dipeptide 2 Inhibitor 97.89% Unkown
HY-N7628 Cassiaside C 99.90% Unkown
HY-P2096 Hexapeptide-11 Inhibitor 99.52% Unkown
HY-P3163 Hexapeptide-9 99.40% Unkown
HY-W286743 Nε-(Carboxymethyl)-L-lysine 99.70% Unkown
HY-W337672 H-Pro-Hyp-OH ≥99.0% Unkown
HY-43515 ESI1 99.76% Unkown
HY-133859 M084 Inhibitor / Unkown
HY-147108 Mitochondria degrader-1 Inducer 95.10% Unkown
HY-163690 HTRA1-IN-1 Inhibitor / Unkown
HY-I0626S2 Cytosine-d2 99.69% Unkown
HY-P0064 Palmitoyl Tetrapeptide-3 Inhibitor 99.20% Unkown
HY-P10409 SHLP2 99.18% Unkown
HY-P2048 MOTS-c (human) 99.90% Unkown
HY-P1930A Risuteganib hydrochloride Inhibitor 98.54% Yes
HY-11053 S 24795 Agonist 99.66% Unkown
HY-132126 SPHINX Inhibitor 99.87% Unkown
HY-153917 CRT0063465 Ligand 99.64% Unkown
HY-N2947 Boeravinone B Inhibitor ≥97.0% Unkown
HY-N3757 (+)-Dihydrorobinetin ≥98.0% Unkown
HY-N9347 Stepharine Inhibitor ≥98.0% Unkown
HY-NP162 Recombinant Humanized Type XVII Collagen / Unkown
HY-P2663 Acetyl tetrapeptide-2 99.70% Unkown
HY-P5251 Oligopeptide-68 98.89% Unkown
HY-W012382S N-Acetyl-L-tyrosine-d3 98.43% Unkown
HY-164159 α-Glucosylrutin Inhibitor 95.76% Unkown
HY-W013494S L-Carnosine-d4 99.00% Unkown
HY-124609 CAD031 Inhibitor 99.39% Unkown
HY-126487A H-Arg-Lys-OH TFA 99.86% Unkown
HY-130221 (25S)-Δ7-Dafachronic acid 95.40% Unkown
HY-139464 Q134R 99.55% Unkown
HY-145486 1-Arachidonoyl-sn-glycerol 3-phosphate ammonium / Unkown
HY-15492 AG-13958 Inhibitor 99.71% Unkown
HY-169266 BRD-K56819078 Inhibitor / Unkown
HY-173463 Sirtuin modulator 8 Modulator / Unkown
HY-65008 N-Demethylricinine 99.94% Unkown
HY-N12486A (3S,8R,9R)-Isofalcarintriol / Unkown
HY-N2284 Sophoflavescenol Inhibitor 98.78% Unkown
HY-N7426 3-Deoxyglucosone / Unkown
HY-Q49697 Sirtuin modulator 3 Modulator 99.32% Unkown
HY-W585874 Nε-(Carboxyethyl)lysine Modulator / Unkown
HY-W701069 Isomyosmine / Unkown
HY-158821 ISTH0036 / Unkown
HY-158821A ISTH0036 sodium / Unkown
HY-N6818R 5,​7,​4'-​Trimethoxyflavone (Standard) / Unkown
HY-107652 AF-DX 384 Antagonist 98.0% Unkown
HY-107811A Harmol hydrochloride / Unkown
HY-113033A Pentosidine TFA / Unkown
HY-113127 L-Tryptophanamide / Unkown
HY-116780A Prothipendyl hydrochloride Inhibitor / Unkown
HY-124223 AF-DX 384 methanesulfonate Antagonist / Unkown
HY-128135 MHY 553 Agonist / Unkown
HY-128387S 2,3-Butanediol-d6 / Unkown
HY-128387S1 2,3-Butanediol-d8 / Unkown
HY-128463S N-tert-Butyl-α-phenylnitrone-d14 / Unkown
HY-131528 Tenilsetam / Unkown
HY-133804 Arteanoflavone Inhibitor / Unkown
HY-133968S1 24-Methylenecholesterol-13C / Unkown
HY-136788A ALK4290 dihydrochloride Inhibitor / Unkown
HY-137557 Florzolotau / Unkown
HY-138830A (S,S)-TAK-418 Inhibitor / Unkown
HY-142778 Lp-PLA2-IN-10 / Unkown
HY-14567A Ciproxifan hydrochloride Antagonist / Unkown
HY-148322 Sirtuin modulator 5 Modulator / Unkown
HY-151487 CypD-IN-3 Inhibitor / Unkown
HY-151488 CypD-IN-4 Inhibitor / Unkown
HY-151489 CypE-IN-1 Inhibitor / Unkown
HY-151546 MRS4596 Antagonist / Unkown
HY-151547 MRS4719 Antagonist / Unkown
HY-153183 Lp-PLA2-IN-12 Inhibitor / Unkown
HY-153560 Lp-PLA2-IN-14 Inhibitor / Unkown
HY-15492A AG-13958 (mono(hydrochloride)) Inhibitor / Unkown
HY-155138 GLS1 Inhibitor-7 Inhibitor / Unkown
HY-155988 Sirtuin modulator 6 Modulator / Unkown
HY-156023 Sirtuin modulator 7 Modulator 99.28% Unkown
HY-157421 Nampt activator-4 Modulator / Unkown
HY-159007 BD-AcAc2 / Unkown
HY-159925 QKY-613 Activator / Unkown
HY-162269 Nampt activator-5 Activator / Unkown
HY-162515 8-OAc / Unkown
HY-162866 CXM102 Activator / Unkown
HY-162904 BPU17 / Unkown
HY-162968 MRTF-A-IN-1 Inhibitor / Unkown
HY-162969 MRTF-A-IN-2 Inhibitor / Unkown
HY-163403 VEGFR-2-IN-43 Inhibitor / Unkown
HY-16561G Resveratrol (GMP) / Unkown
HY-16561S1 Resveratrol-13C6 / Unkown
HY-167740 Glycerophosphoinositol (lysine) / Unkown
HY-168336 E0924G Activator 99.17% Unkown
HY-169204 Mito-fisetin mF3 Inhibitor / Unkown
HY-169265 BRD-K20733377 Inhibitor / Unkown
HY-170794 ALT-007 Inhibitor / Unkown
HY-66018 Palmitoyl tripeptide-5 biTFA / Unkown
HY-B0801AS Fexofenadine-d10 hydrochloride Inhibitor / Unkown
HY-B1340S Carbadox-d3 Inhibitor / Unkown
HY-E70022 D-Mannose isomerase (PsMaSeAF) / Unkown
HY-E70410 NAD Synthetase / Unkown
HY-I0626S Cytosine-13C2,15N3 / Unkown
HY-I0626S1 Cytosine-13C,15N2 / Unkown
HY-N0679S Retinyl acetate-d3 / Unkown
HY-N1097 Venoterpine / Unkown
HY-N12653 Exserohilone Inhibitor / Unkown
HY-N13232 Grape Skin Extract / Unkown
HY-N13380 6′‐O‐Galloylsalidroside / Unkown
HY-N15152 Isoaesculioside D / Unkown
HY-N1517A (Rac)-Ganoderic acid C2 Inhibitor / Unkown
HY-N15225 12β-Hydroxyganoderenic acid B / Unkown
HY-N2550 (+)-Coclaurine / Unkown
HY-N3612 Communic acid Inhibitor / Unkown
HY-N6883 6-Methoxytricin Inhibitor / Unkown
HY-N8375 Sieboldin Inhibitor / Unkown
HY-P0095 Acetyl tetrapeptide-5 Inhibitor 98.05% Unkown
HY-P0099 Pentapeptide-3 Antagonist 99.73% Unkown
HY-P0104 Palmitoyl tripeptide-38 Inhibitor / Unkown
HY-P10140 JNK-IN-15, Cell-Permeable Inhibitor / Unkown
HY-P10141 JNK-IN-15, Cell-Permeable, Negative Control Inhibitor / Unkown
HY-P10611 [D-Ser14]-Humanin / Unkown
HY-P4308 Z-Pro-Pro-aldehyde-dimethyl acetal Inhibitor / Unkown
HY-P5233 Acetyltetrapeptide 11 Inhibitor / Unkown
HY-P5250 Palmitoyl tripeptide-5 Inhibitor / Unkown
HY-RS00444 AGER Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W127725 Thymolphthalexon tetrasodium / Unkown
HY-W127738 6-O-Stearoyl-L-ascorbic acid / Unkown
HY-Y0785 Glyoxal / Unkown
HY-107758 Y-29794 oxalate Inhibitor / Unkown
HY-113033 Pentosidine / Unkown
HY-123754 AGN-201904 Inhibitor / Unkown
HY-123904 UoS12258 Activator 99.86% Unkown
HY-142025 Daumone / Unkown
HY-145545 1-Stearoyl-2-Adrenoyl-sn-glycero-3-PE / Unkown
HY-14567 Ciproxifan Antagonist 99.26% Unkown
HY-149708 UCM-13207 Inhibitor 99.61% Unkown
HY-154951 Oct4 inducer-2 Inducer / Unkown
HY-161088 Anti-aging agent 1 Inhibitor / Unkown
HY-163103 (S)-Isomyosmine / Unkown
HY-164066 Sodium Acetylated Hyaluronate / Unkown
HY-168957 RuDiOBn Inhibitor / Unkown
HY-169085 LRAT-IN-1 Inhibitor / Unkown
HY-N1190 DL-Syringaresinol Inhibitor / Unkown
HY-N12071 Lucidin-ω-Me ether / Unkown
HY-N12486 Isofalcarintriol / Unkown
HY-N13299 Glucoberteroin / Unkown
HY-N15147 Panax saponin C Activator / Unkown
HY-N8380 (-)-Latifolin / Unkown
HY-P3164 Acetyl tetrapeptide-9 / Unkown
HY-W268155 3,4'-Dihydroxypropiophenone 95.35% Unkown
HY-W722107 Timonacic-d4 / Unkown
HY-W747597 Ganglioside GD1b Disodium Salt (Bovine Brain) / Unkown
HY-W997836 4-Amino-3-hydroxyphenylalanine / Unkown
Inhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9951A Ranibizumab (anti-VEGF) Inhibitor 98.51% Unkown
HY-P99905 Efdamrofusp alfa / Unkown
HY-P990328 Anti-AGER/RAGE Antibody (XT-M4) Inhibitor ≥99.0% Unkown
HY-P99402 Rinucumab Inhibitor 98.89% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens AGER NCBI NCBI:177
Mus musculus AGER NCBI NCBI:11596